Jean Viallet

6.8k total citations · 1 hit paper
102 papers, 5.6k citations indexed

About

Jean Viallet is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jean Viallet has authored 102 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 34 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jean Viallet's work include Cell death mechanisms and regulation (15 papers), Cancer therapeutics and mechanisms (12 papers) and Lung Cancer Treatments and Mutations (12 papers). Jean Viallet is often cited by papers focused on Cell death mechanisms and regulation (15 papers), Cancer therapeutics and mechanisms (12 papers) and Lung Cancer Treatments and Mutations (12 papers). Jean Viallet collaborates with scholars based in Canada, United States and France. Jean Viallet's co-authors include Ming‐Sound Tsao, John D. Minna, J. Schütte, Marion M. Nau, J Fedorko, J D Minna, Shoshana Segal, Danielle Dhouailly, Adi F. Gazdar and Gordon C. Shore and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jean Viallet

100 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis

2007 538 citations Jean Viallet, Gordon C. Shore et al. profile →

Peers

Countries citing papers authored by Jean Viallet

Since Specialization

Citations

This map shows the geographic impact of Jean Viallet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Viallet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Viallet more than expected).

Fields of papers citing papers by Jean Viallet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Viallet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Viallet. The network helps show where Jean Viallet may publish in the future.

Co-authorship network of co-authors of Jean Viallet

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Viallet. A scholar is included among the top collaborators of Jean Viallet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Viallet. Jean Viallet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Liver cancer in ovo models for preclinical testing 2024 ·The FASEB Journal ·(unknown), (unknown), Jean Viallet, (unknown), (unknown), Thomas Decaens, Anouk Emadali, Zuzana Macek Jílková	0
2	Abstract 4018: An innovative in vivo model for CAR-T cell therapy development: Tolerability and efficacy evaluation of CD19-targeting CAR-T cells on human lymphoma using the chicken CAM assay 2024 ·Cancer Research ·Yan Wang, Xavier Rousset, Chloé Prunier, (unknown), Alejandra Gutiérrez-Guerrero, (unknown), (unknown), Jean Viallet	1
3	The CAM Model—Q&A with Experts 2022 ·Cancers ·Dagmar Fischer, Georg Fluegen, (unknown), Nassim Ghaffari‐Tabrizi‐Wizsy, Laura Gribaldo, Ruby Yun‐Ju Huang, Volker Rasche, Doménico Ribatti, Xavier Rousset, Marta Pinto, Jean Viallet, Yan Wang, Regine Schneider‐Stock	38
4	Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept 2022 ·Cancers ·Xavier Rousset, Denis Maillet, (unknown), (unknown), Sara Calattini, Marie Brevet, (unknown), (unknown), (unknown), Jessica Garcia, Myriam Decaussin‐Petrucci, Julien Péron, Nazim Benzerdjeb, S. Couraud, Jean Viallet, Léa Payen	9
5	PD-1/PD-L1 Checkpoint Inhibitors Are Active in the Chicken Embryo Model and Show Antitumor Efficacy In Ovo 2022 ·Cancers ·Yan Wang, Xavier Rousset, Chloé Prunier, (unknown), (unknown), (unknown), Jean Viallet	9
6	Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy 2018 ·Cancer Immunology Immunotherapy ·Michele Maio, George Coukos, Soldano Ferrone, Bernard A. Fox, Wolf H. Fridman, Patrick L. Garcia, Michael Lahn, (unknown), Vincenzo Russo, Dominik Rüttinger, Aiman Shalabi, Zlatko Trajanoski, Jean Viallet, Jedd D. Wolchok, Ramy Ibrahim	8
7	LKB1 signaling in cephalic neural crest cells is essential for vertebrate head development 2016 ·Developmental Biology ·Sophie Creuzet, Jean Viallet, (unknown), Sakina Torch, Jacques Thélu, (unknown), A Radu, Daniel Bouvard, (unknown), (unknown), Karine Buchet-Poyau, Nicolas Aznar, Sylvie Büschlen, Hiroshi Hosoya, Chantal Thibert, Marc Billaud	8
8	Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism 2013 ·Cancer Research ·Ivan Mikaélian, Mouhannad Malek, Rudy Gadet, Jean Viallet, (unknown), (unknown), Cédric Hesling, Germain Gillet, Philippe Gonzalo, Ruth Rimokh, Marc Billaud	47
9	Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma 2010 ·Clinical Cancer Research ·Jimmy J. Hwang, John Kuruvilla, David S. Mendelson, Michael J. Pishvaian, John F. Deeken, Lillian L. Siu, Mark S. Berger, Jean Viallet, John L. Marshall	80
10	Mechanisms of Antileukemic Activity of the Novel Bcl-2 Homology Domain-3 Mimetic GX15-070 (Obatoclax) 2008 ·Cancer Research ·Marina Konopleva, Julie C. Watt, Rooha Contractor, Twee Tsao, David Harris, Zeev Estrov, William G. Bornmann, Hagop Kantarjian, Jean Viallet, Ismael Samudio, Michael Andreeff	215
11	Functional Interaction of Aurora-A and PP2A during Mitosis 2007 ·Molecular Biology of the Cell ·(unknown), Jacques Thélu, Alphonse Garcı́a, Corinne Albigès‐Rizo, Marc R. Block, Jean Viallet	46
12	Modulating the Bcl-2 Family of Apoptosis Suppressors for Potential Therapeutic Benefit in Cancer 2005 ·Hematology ·Gordon C. Shore, Jean Viallet	70
13	Use of Penetrating Peptides Interacting with PP1/PP2A Proteins As a General Approach for a Drug Phosphatase Technology 2005 ·Molecular Pharmacology ·Julien Guergnon, Frédéric Dessauge, Victoria Domínguez Del Angel, Jean Viallet, Serge Bonnefoy, Vı́ctor J. Yuste, Odile Mercereau‐Puijalon, Xavier Cayla, Angelita Rebollo, Santos A. Susín, (unknown), Alphonse Garcı́a	46
14	Drm/Gremlin, a BMP antagonist, defines the interbud region during feather development. 2004 ·The International Journal of Developmental Biology ·Boris Bardot, Laure Lecoin, Ingrid Fliniaux, Emmanuelle Huillard, Maria Marx, Jean Viallet	25
15	Skin field formation: morphogenetic events. 2004 ·The International Journal of Developmental Biology ·Danielle Dhouailly, Isabel Olivera-Martínez, Ingrid Fliniaux, (unknown), Jean Viallet, Jacques Thélu	33
16	Ventral vs. dorsal chick dermal progenitor specification. 2004 ·The International Journal of Developmental Biology ·Ingrid Fliniaux, Jean Viallet, Danielle Dhouailly	17
17	Characterization of Human Bronchial Epithelial Cells Immortalized by the E6 and E7 Genes of Human Papillomavirus Type 16 1994 ·Experimental Cell Research ·Jean Viallet, Chi Liu, (unknown), Ming‐Sound Tsao	43
18	Small cell carcinoma of the lung: clinical and biologic aspects 1991 ·Critical Reviews in Oncology/Hematology ·Jean Viallet, Daniel C. Ihde	17
19	Cholera toxin inhibits signal transduction by several mitogens and the in vitro growth of human small-cell lung cancer. 1990 ·Journal of Clinical Investigation ·Jean Viallet, Yoav Sharoni, Harold Frucht, Robert T. Jensen, John D. Minna, Edward A. Sausville	28
20	Dominant Oncogenes and Tumor Suppressor Genes in the Pathogenesis of Lung Cancer 1990 ·American Journal of Respiratory Cell and Molecular Biology ·Jean Viallet, John D. Minna	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact